NEURALSTEM, INC. Chart calendar Neuralstem, Inc.
58d48c8f3cdb8a59792a17b18d9c55.fRxp4s6A_434jgJ97NMzDrpT0xf3OwFZ4O6O18Bx2cM.G1Qe0vbEmcCA7E4WjYN9V80V5mGzVnMwh4jEj7cUi_o3XRGytrWY-6fgNg~354b673099d85ffbd6c6913384017b0f
Upcoming events on Neuralstem, Inc.
Past events on Neuralstem, Inc.
| 2024-07-08 01:00 pm | Annual General Meeting |
| 2024-06-26 04:00 pm | Virtual Investor Closing Bell Series |
| 2024-06-17 12:00 pm | Virtual Investor Pitch Conference |
| 2024-05-21 12:30 pm | Digestive Disease Week Conference |
| 2024-05-14 08:05 am | Q1 2024 Earnings Release |
| 2024-04-16 12:00 pm | Virtual Investor Lunch Break Conference |
| 2024-04-08 | IBD Innovate Product Development for Crohn & Colitis Conference |
| 2024-04-07 | Reverse Split: 1 of 15 |
| 2024-03-27 08:00 am | Q4 2023 Earnings Release |
| 2024-03-24 | Extraordinary Shareholders Meeting |
| 2024-01-26 10:00 pm | Crohn Colitis Congress |
| 2023-11-10 08:05 am | Q3 2023 Earnings Release |
| 2023-10-25 02:00 pm | Ask the CEO Virtual Investor Conference |
| 2023-08-11 08:05 am | Q2 2023 Earnings Release |
| 2023-06-22 11:30 am | Maxim Group Virtual Healthcare Conference |
| 2023-06-08 01:00 pm | Annual General Meeting |
| 2023-05-12 08:05 am | Q1 2023 Earnings Release |
| 2023-03-23 08:05 am | Q4 2022 Earnings Release |
| 2023-01-17 03:00 pm | Virtual Investor Conference |
| 2022-11-15 | Reverse Split: 1 of 50 |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,25 0,25 0% | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -41,9 -41,2 -1.67% | -15,3 -15,4 0.82% | -13,1 -12,8 -2.3% | -15,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -26,6 -29,1 8.4% | -14,3 -14,1 -1.08% | -12,3 -12,2 -0.89% | -14,8 |
|
Net income Million USD | Released Forecast Spread | -26,6 -33,1 19.59% | -14,3 -14,3 0.36% | -12,3 -12,4 0.59% | -14,8 |
|
EPS USD | Released Forecast Spread | -2 145 -2 947 27.23% | -248 -321 22.87% | -27,0 -28,1 4% | -11,7 |
| Announcement Date | 17/03/22 | 22/03/23 | 26/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,25 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -3,89 -3,92 0.92% | -3,57 -3,35 -6.63% | -4,00 -3,72 -7.71% | -3,85 -3,77 -2.07% | -2,53 -3,66 30.94% | -3,61 -3,10 -16.36% | -3,78 -3,35 -12.84% | -3,15 -3,04 -3.7% | -3,67 -3,16 -16.2% | -3,70 | -3,77 | -3,83 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -4,21 -3,92 -7.16% | -2,34 -3,35 30.03% | -3,99 -3,72 -7.39% | -3,72 -3,77 1.38% | -2,34 -3,66 36.13% | -3,39 -3,10 -9.35% | -3,60 -3,35 -7.28% | -2,97 -3,04 2.38% | -3,53 -3,16 -11.58% | -3,70 | -3,76 | -3,83 |
|
Net income Million USD | Released Forecast Spread | -4,21 -3,92 -7.16% | -2,34 -3,35 30.03% | -3,99 -3,72 -7.39% | -3,72 -3,77 1.38% | -2,34 -3,66 36.13% | -3,39 -3,10 -9.35% | -3,60 -3,35 -7.28% | -2,97 -3,04 2.38% | -3,53 -3,16 -11.58% | -3,70 | -3,76 | -3,83 |
|
EPS USD | Released Forecast Spread | -195 -210 7.14% | -90,0 -127 29.41% | -60,0 -60,0 0% | -89,8 -36,5 -146% | -8,10 -10,9 25.52% | -7,95 -6,83 -16.48% | -7,35 -6,15 -19.51% | -3,75 -5,18 27.54% | -4,59 -3,75 -22.4% | -2,93 | -2,48 | -1,98 |
| Announcement Date | 13/05/22 | 15/08/22 | 14/11/22 | 22/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | 26/03/24 | 13/05/24 | - | - | - |
